Which tests measure Non-HDL Cholesterol?

Non-HDL Cholesterol is measured in 1 test on BiomarkersLabs.com, including Lipid Panel (Total Cholesterol, LDL-C, HDL-C, Triglycerides, Non-HDL-C).

Biomarker Reference · Non-HDL-C

What does the Non-HDL Cholesterol test measure?

Q: Why is Non-HDL Cholesterol measured?

Non-HDL-C is endorsed by ACC/AHA 2018, ESC/EAS 2019, and NLA guidelines as a secondary lipid target that is superior to LDL-C for total atherogenic burden characterisation — particularly in patients with hypertriglyceridaemia and metabolic syndrome, where LDL-C underestimates the atherogenic particle burden represented by VLDL and IDL remnant cholesterol. Non-HDL-C is the single most practical risk marker in non-fasting specimens, where LDL-C Friedewald calculation is unreliable. In the full lipid panel, non-HDL-C should be interpreted alongside LDL-C — when non-HDL-C is disproportionately elevated relative to LDL-C (non-HDL-C − LDL-C >30 mg/dL), it signals elevated remnant cholesterol from VLDL and IDL, the lipid phenotype of insulin resistance and metabolic syndrome, warranting triglyceride reduction strategies in addition to LDL-C management.

Q: What is the reference range for Non-HDL Cholesterol?

The standard reference range for Non-HDL Cholesterol is Optimal: <130 mg/dL (<3.36 mmol/L); Borderline high: 130–159 mg/dL; High: 160–189 mg/dL; Very high: ≥190 mg/dL # REVIEWER FLAG: Confirm LabCorp reporting of non-HDL-C — confirm whether it is calculated and reported automatically (as TC − HDL-C) on the LabCorp Lipid Panel or whether it requires a separate derivation. Non-HDL-C risk thresholds above reflect NCEP ATP III; ACC/AHA 2018 and ESC/EAS 2019 frameworks set non-HDL-C targets 30 mg/dL above the corresponding LDL-C target.. Reference ranges vary by laboratory and assay platform — interpret in context of the issuing laboratory's stated range.

Non-HDL Cholesterol (Non-HDL-C) is a clinical biomarker used in cardiovascular assessment. Non-HDL cholesterol is a mathematically derived value — total cholesterol minus HDL cholesterol — capturing cholesterol carried in all atherogenic lipoprotein particles simultaneously: LDL, VLDL, IDL, lipoprotein(a), and chylomicron remnants. It is measured in 1 laboratory test on BiomarkersLabs.com.

Reference Range: Optimal: <130 mg/dL (<3.36 mmol/L); Borderline high: 130–159 mg/dL; High: 160–189 mg/dL; Very high: ≥190 mg/dL # REVIEWER FLAG: Confirm LabCorp reporting of non-HDL-C — confirm whether it is calculated and reported automatically (as TC − HDL-C) on the LabCorp Lipid Panel or whether it requires a separate derivation. Non-HDL-C risk thresholds above reflect NCEP ATP III; ACC/AHA 2018 and ESC/EAS 2019 frameworks set non-HDL-C targets 30 mg/dL above the corresponding LDL-C target.
Units: mg/dL, mmol/L
Measured In: 1 test
Category: Cardiovascular

Functional medicine optimal<100 mg/dL (very-high-risk patients per ESC/EAS 2019, corresponding to LDL-C target <70 mg/dL); <130 mg/dL (ACC/AHA 2018 guideline secondary target for high-risk patients); <70 mg/dL (ultra-low risk functional preventive target corresponding to LDL-C <40 mg/dL). # REVIEWER FLAG: Non-HDL-C targets are risk-stratified — reviewer to confirm which guideline framework is appropriate for the platform audience.

What is Non-HDL Cholesterol?

Non-HDL cholesterol is a mathematically derived value — total cholesterol minus HDL cholesterol — capturing cholesterol carried in all atherogenic lipoprotein particles simultaneously: LDL, VLDL, IDL, lipoprotein(a), and chylomicron remnants. Because each of these particle types carries a single ApoB-100 (or ApoB-48 for chylomicrons) molecule, non-HDL-C provides an integrated measure of the total atherogenic lipoprotein cholesterol burden that includes the full atherogenic particle spectrum, unlike LDL-C which captures only the LDL fraction. Non-HDL-C requires no calculation assumptions or fasting specimen corrections — it is derivable from any lipid panel regardless of fasting status or triglyceride level, making it the preferred lipid target in non-fasting specimens.

Why is Non-HDL Cholesterol measured?

Non-HDL-C is endorsed by ACC/AHA 2018, ESC/EAS 2019, and NLA guidelines as a secondary lipid target that is superior to LDL-C for total atherogenic burden characterisation — particularly in patients with hypertriglyceridaemia and metabolic syndrome, where LDL-C underestimates the atherogenic particle burden represented by VLDL and IDL remnant cholesterol. Non-HDL-C is the single most practical risk marker in non-fasting specimens, where LDL-C Friedewald calculation is unreliable. In the full lipid panel, non-HDL-C should be interpreted alongside LDL-C — when non-HDL-C is disproportionately elevated relative to LDL-C (non-HDL-C − LDL-C >30 mg/dL), it signals elevated remnant cholesterol from VLDL and IDL, the lipid phenotype of insulin resistance and metabolic syndrome, warranting triglyceride reduction strategies in addition to LDL-C management.

Reference ranges

Standard reference: Optimal: <130 mg/dL (<3.36 mmol/L); Borderline high: 130–159 mg/dL; High: 160–189 mg/dL; Very high: ≥190 mg/dL # REVIEWER FLAG: Confirm LabCorp reporting of non-HDL-C — confirm whether it is calculated and reported automatically (as TC − HDL-C) on the LabCorp Lipid Panel or whether it requires a separate derivation. Non-HDL-C risk thresholds above reflect NCEP ATP III; ACC/AHA 2018 and ESC/EAS 2019 frameworks set non-HDL-C targets 30 mg/dL above the corresponding LDL-C target.
Functional medicine optimal: <100 mg/dL (very-high-risk patients per ESC/EAS 2019, corresponding to LDL-C target <70 mg/dL); <130 mg/dL (ACC/AHA 2018 guideline secondary target for high-risk patients); <70 mg/dL (ultra-low risk functional preventive target corresponding to LDL-C <40 mg/dL). # REVIEWER FLAG: Non-HDL-C targets are risk-stratified — reviewer to confirm which guideline framework is appropriate for the platform audience.
Units: mg/dL, mmol/L

Reference ranges vary by laboratory and assay platform. Interpret in context of the issuing laboratory's stated range.

Tests that measure Non-HDL Cholesterol

1 test on BiomarkersLabs.com include this biomarker.

BML-CAR-003Comprehensive

Lipid Panel (Total Cholesterol, LDL-C, HDL-C, Triglycerides, Non-HDL-C)

Non-HDL Cholesterol reference range in this test: Optimal: <130 mg/dL (<3.36 mmol/L); Borderline high: 130–159 mg/dL; High: 160–189 mg/dL; Very high: ≥190 mg/dL # REVIEWER FLAG: Confirm LabCorp reporting of non-HDL-C — confirm whether it is calculated and reported automatically (as TC − HDL-C) on the LabCorp Lipid Panel or whether it requires a separate derivation. Non-HDL-C risk thresholds above reflect NCEP ATP III; ACC/AHA 2018 and ESC/EAS 2019 frameworks set non-HDL-C targets 30 mg/dL above the corresponding LDL-C target.

Related clinical conditions

Related Biomarkers

Frequently measured alongside

Total CholesterolTC1 test LDL Cholesterol (Low-Density Lipoprotein Cholesterol)LDL-C1 test HDL Cholesterol (High-Density Lipoprotein Cholesterol)HDL-C1 test TriglyceridesTG1 test VLDL Cholesterol (Very Low-Density Lipoprotein Cholesterol)VLDL-C1 test

Order tests measuring Non-HDL Cholesterol for your patients

Available exclusively to verified licensed healthcare practitioners. CLIA-certified laboratory results delivered to your secure portal.